Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer Disease; Prodromal”

69 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 69 results

Testing effectiveness (Phase 2)Ended earlyNCT00890890
What this trial is testing

A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Bristol-Myers Squibb 263
Large-scale testing (Phase 3)Ended earlyNCT03114657
What this trial is testing

Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Hoffmann-La Roche 806
Large-scale testing (Phase 3)Ended earlyNCT01953601
What this trial is testing

Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019)

Who this might be right for
Amnestic Mild Cognitive ImpairmentAlzheimer's DiseaseProdromal Alzheimer's Disease
Merck Sharp & Dohme LLC 1,454
Not applicableStudy completedNCT04004767
What this trial is testing

TRC-PAD Program: In-Clinic Trial-Ready Cohort

Who this might be right for
Preclinical Alzheimer's DiseaseProdromal Alzheimer's DiseaseAlzheimer Disease+1 more
University of Southern California 220
Early research (Phase 1)Study completedNCT04566003
What this trial is testing

Evaluation Comparing Tau PET Radiotracers, [18F]GTP1 and [18F]PI-2620 or [18F]MK-6240 in Subjects With Normal Cognition or Prodromal to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease (AD)
Genentech, Inc. 40
Large-scale testing (Phase 3)Ended earlyNCT02956486
What this trial is testing

A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eisai Co., Ltd. 2,212
Testing effectiveness (Phase 2)Looking for participantsNCT04804241
What this trial is testing

Senicapoc in Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentAlzheimer Disease
University of California, Davis 55
Early research (Phase 1)Study completedNCT02127476
What this trial is testing

Single and Multiple Doses of KHK6640 in Subjects With Prodromal or Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Kyowa Kirin Co., Ltd. 57
Not applicableUnknownNCT04928690
What this trial is testing

Prediction of Amyloid and Mild Cognitive Impairment in Early Stage Alzheimer's Disease From Remote Speech Phenotyping

Who this might be right for
Alzheimer DiseaseAlzheimer's Disease (Incl Subtypes)Mild Cognitive Impairment
Novoic Limited 140
Not applicableStudy completedNCT03834402
What this trial is testing

INTERCEPTOR Project: From MCI to Dementia

Who this might be right for
Mild Cognitive ImpairmentAlzheimer Disease
Catholic University of the Sacred Heart 500
Not applicableUnknownNCT04937959
What this trial is testing

Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - PAST Extension

Who this might be right for
Alzheimer DiseaseAlzheimer's Disease (Incl Subtypes)Preclinical Alzheimer's Disease+3 more
Novoic Limited 40
Not applicableStudy completedNCT05309577
What this trial is testing

Self-Care for Dementia Caregivers

Who this might be right for
AgingMental DisorderEating, Healthy+6 more
University of Pittsburgh 21
Not applicableEnded earlyNCT04846426
What this trial is testing

Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - FUTURE Extension

Who this might be right for
Alzheimer DiseasePreclinical Alzheimer's DiseaseProdromal Alzheimer's Disease+2 more
Novoic Limited 67
Early research (Phase 1)Ended earlyNCT01677572
What this trial is testing

Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Biogen 197
Not applicableUnknownNCT03138018
What this trial is testing

Aging Stereotypes and Prodromal Alzheimer's Disease

Who this might be right for
Mild Cognitive Impairment (MCI)
Assistance Publique Hopitaux De Marseille 260
Not applicableLooking for participantsNCT04029623
What this trial is testing

Partnered Rhythmic Rehabilitation in Prodromal Alzheimer's Disease

Who this might be right for
Prodromal Alzheimer's Disease
Emory University 66
Not applicableLooking for participantsNCT04992975
What this trial is testing

Brain Iron Toxicity and Neurodegeneration - A 7T MRI Study

Who this might be right for
Prodromal Alzheimer's DiseaseMild Cognitive Impairment
Nottingham University Hospitals NHS Trust 40
Testing effectiveness (Phase 2)Study completedNCT05063539
What this trial is testing

LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 327
Large-scale testing (Phase 3)Study completedNCT01224106
What this trial is testing

Gantenerumab in Participants With Prodromal Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Hoffmann-La Roche 799
Early research (Phase 1)Study completedNCT04468347
What this trial is testing

Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
Avid Radiopharmaceuticals 89
Load More Results